Developer docs
API playgroundTry for free, no card

Search company profiles

Labyes

Full company profile

uuid00274d9

Namestring
Labyes
Legal namestring
Labyes S.A.
Websiteurl
labyes.com
Company typeenum
Private
Founded yearint
1985
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMoron, Argentina
HQ citystring
Moron
HQ countrystring
Argentina
HQ regionstring
Latin America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal health products, pet medications, small animal drugs, veterinary medicines
Industry3 codes
1Generic & Private-Label Veterinary Pharmaceuticals
CodeHLAMAEAMPrimaryYes
2Pain Management, Anesthesia & Critical Care Drugs
CodeHLAMAEAFPrimaryNo
3Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid)
CodeHLAMAEAGPrimaryNo
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Veterinary Pharmaceuticals
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Veterinary pharmaceutical product sales
TypeOne Time License
Description

Labyes generates revenue through the sale of its veterinary pharmaceutical products for small animals (dogs and cats), distributed exclusively through authorized distributors across 20 active country markets in Latin America, Asia, and the Middle East.

labyes.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Labyderm
Description

Dermocosmetic line for protecting or repairing the cutaneous barrier in pets

labyes.com
+5 more records
Core offering1 text field

Labyes develops, manufactures, and distributes proprietary veterinary pharmaceutical products for small animals (dogs and cats). Founded in 1985 in Argentina, the company supplies its products through authorized distributors across approximately 20 countries, with regulatory oversight requiring a registered veterinarian as Technical Director.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Active presence in 20 countries across Latin America, Asia, and the Middle East.
+2 more records
Product overview1 text field

Labyes is a veterinary pharmaceutical company specializing in medicines for small animals (pets). The company offers a diversified portfolio organized into 7 product lines: Antibiotic (Azithromycin), Parasite Treatment (Protech Spray, Feline Endospot, Feline Fullspot, Canis Endospot, Canis Fullspot, Fider, Protech Dogs), Dermatological (Otiflex C, Otiflex Cleanser, Labyderm Premium Cover, Labyderm Skin Soldier, Labyderm Bioforce, 6A Cream), Senior Care (Gerioox), Digestive/Hepatic (Trihepat), Ophthalmic (Tau Ophthalmic, Tau Ophthalmic with Steroids, Tears, Ocubiotic, Ocubiotic with Steroids, Tobramax, Ciprovet), and Osteoarticular (Osteocart Plus, Chondroitin). Products are sold through authorized distributors to veterinary clinics and pet owners, with presence in 20+ countries. The company has 28 products for dogs and 26 products for cats totaling over 180 SKUs.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1University of Buenos Aires - School of Veterinary Sciences
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-01-01
Description

Since 2013, Labyes has maintained an agreement with the School of Veterinary Sciences of the University of Buenos Aires to offer veterinary students in their final year an opportunity to participate in an Internship Program. Participants join the technical-commercial team and receive on-the-job training while working as Technical Advisors, with flexible hours to accommodate university studies.

2NGOs and Animal Welfare Organizations
Strategic tierMinorTypeOthers
Description

Labyes responds to sponsorship and product donation requests from reputable non-governmental organizations committed to the development of the veterinary profession and animal care. Donations are evaluated by the Social Responsibility Committee and require a formal letter, proof of legal entity status, and veterinary oversight.

Peers10 records
1Vetnil
TypeRegional player
Description

Brazilian veterinary pharmaceutical and nutraceutical company focused on companion animals and equine. Comparable product mix (anti-parasitics, dermatology, supplements) and similar regional LATAM distribution model.

2Ourofino Pet
TypeRegional player
Description

Brazilian veterinary pharmaceutical manufacturer focused on companion animals, livestock, and pets. Directly comparable to Labyes as a regional Latin American competitor with overlapping therapeutic categories.

3MSD Animal Health (Merck Animal Health)
TypeBroad incumbent
Description

Animal health division of Merck/MSD offering pharmaceuticals, vaccines, and parasiticides globally. Major incumbent competitor across Labyes' therapeutic categories.

4Elanco Animal Health
TypeBroad incumbent
Description

Global animal health major formed from Eli Lilly's animal health unit, with extensive companion-animal product lines. Comparable end-markets, but significantly greater scale and resources than Labyes.

5Virbac
TypeDirect peer
Description

Independent, family-influenced global animal health company specializing in companion-animal pharmaceuticals and vaccines across more than 100 countries. Highly comparable to Labyes given similar veterinary pharma focus and multi-region distribution model.

6Zoetis
TypeBroad incumbent
Description

The world's largest pure-play animal health company with a full portfolio across companion animals and livestock. Represents the dominant incumbent Labyes competes against in LATAM and Asia.

7Dechra Pharmaceuticals
TypeDirect peer
Description

Specialty veterinary pharmaceuticals company focused on companion animals with strong positions in endocrinology, dermatology, and ophthalmology. Closely comparable to Labyes' therapeutic line-up and small-animal focus.

8Vetoquinol
TypeDirect peer
Description

Independent global animal health group focused on companion animals and livestock with strong LATAM presence. Directly comparable to Labyes in product mix (parasiticides, anti-infectives, dermatology) and family-controlled governance.

9Ceva Santé Animale
TypeDirect peer
Description

Privately held global animal health company with leadership positions in companion-animal pharmaceuticals, vaccines, and devices. Comparable in scale, specialty pharma focus, and privately held structure.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Top-3 global animal health division of Boehringer Ingelheim, with major parasiticides and vaccine franchises. A key global competitor whose commercial scale dwarfs Labyes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Labyes

Veterinary Pharmaceuticalslabyes.com

Labyes firmographics

Firmographics
Name
Labyes
Legal name
Labyes S.A.
Website
https://labyes.com
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Labyes industry classification

Industry
Product category
Veterinary Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)
akta.pro secondary industries
Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF), Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG)

Keywords

  • Veterinary pharmaceuticals
  • Animal health products
  • Pet medications
  • Small animal drugs
  • Veterinary medicines

Where Labyes is headquartered

Location

Headquarters

HQ city
Moron
HQ country
Argentina
HQ region
Latin America

Offices4 records

Markets served

Labyes business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Revenue model

  1. Veterinary pharmaceutical product sales: Labyes generates revenue through the sale of its veterinary pharmaceutical products for small animals (dogs and cats), distributed exclusively through authorized distributors across 20 active country markets in Latin America, Asia, and the Middle East.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Labyes product offering

Product offering

Core offering

Labyes develops, manufactures, and distributes proprietary veterinary pharmaceutical products for small animals (dogs and cats). Founded in 1985 in Argentina, the company supplies its products through authorized distributors across approximately 20 countries, with regulatory oversight requiring a registered veterinarian as Technical Director.

Product overview

Labyes is a veterinary pharmaceutical company specializing in medicines for small animals (pets). The company offers a diversified portfolio organized into 7 product lines: Antibiotic (Azithromycin), Parasite Treatment (Protech Spray, Feline Endospot, Feline Fullspot, Canis Endospot, Canis Fullspot, Fider, Protech Dogs), Dermatological (Otiflex C, Otiflex Cleanser, Labyderm Premium Cover, Labyderm Skin Soldier, Labyderm Bioforce, 6A Cream), Senior Care (Gerioox), Digestive/Hepatic (Trihepat), Ophthalmic (Tau Ophthalmic, Tau Ophthalmic with Steroids, Tears, Ocubiotic, Ocubiotic with Steroids, Tobramax, Ciprovet), and Osteoarticular (Osteocart Plus, Chondroitin). Products are sold through authorized distributors to veterinary clinics and pet owners, with presence in 20+ countries. The company has 28 products for dogs and 26 products for cats totaling over 180 SKUs.

Differentiator

Problem solved

Functional benefit

Brands

  • Labyderm: Dermocosmetic line for protecting or repairing the cutaneous barrier in pets
  • Gerioox
  • Protech
  • Fider
  • Trihepat
  • Azithromycin

Quantifiable outcome

  • Active presence in 20 countries across Latin America, Asia, and the Middle East.
  • +2 more outcomes

Companies that use Labyes

Customer profile

Named customers3 records

Segments3 records

Labyes technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature11 records

Labyes partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • University of Buenos Aires - School of Veterinary SciencescoreStrategic or Co-development Partner · 1 January 2013Since 2013, Labyes has maintained an agreement with the School of Veterinary Sciences of the University of Buenos Aires to offer veterinary students in their final year an opportunity to participate in an Internship Program. Participants join the technical-commercial team and receive on-the-job training while working as Technical Advisors, with flexible hours to accommodate university studies.
  • NGOs and Animal Welfare OrganizationsminorOthersLabyes responds to sponsorship and product donation requests from reputable non-governmental organizations committed to the development of the veterinary profession and animal care. Donations are evaluated by the Social Responsibility Committee and require a formal letter, proof of legal entity status, and veterinary oversight.

Scale indicators9 records

Labyes competitors and assessment

Company assessment

Regional players

  • Vetnil: Brazilian veterinary pharmaceutical and nutraceutical company focused on companion animals and equine. Comparable product mix (anti-parasitics, dermatology, supplements) and similar regional LATAM distribution model.
  • Ourofino Pet: Brazilian veterinary pharmaceutical manufacturer focused on companion animals, livestock, and pets. Directly comparable to Labyes as a regional Latin American competitor with overlapping therapeutic categories.

Broad incumbents

  • MSD Animal Health (Merck Animal Health): Animal health division of Merck/MSD offering pharmaceuticals, vaccines, and parasiticides globally. Major incumbent competitor across Labyes' therapeutic categories.
  • Elanco Animal Health: Global animal health major formed from Eli Lilly's animal health unit, with extensive companion-animal product lines. Comparable end-markets, but significantly greater scale and resources than Labyes.
  • Zoetis: The world's largest pure-play animal health company with a full portfolio across companion animals and livestock. Represents the dominant incumbent Labyes competes against in LATAM and Asia.
  • Boehringer Ingelheim Animal Health: Top-3 global animal health division of Boehringer Ingelheim, with major parasiticides and vaccine franchises. A key global competitor whose commercial scale dwarfs Labyes.

Direct peers

  • Virbac: Independent, family-influenced global animal health company specializing in companion-animal pharmaceuticals and vaccines across more than 100 countries. Highly comparable to Labyes given similar veterinary pharma focus and multi-region distribution model.
  • Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company focused on companion animals with strong positions in endocrinology, dermatology, and ophthalmology. Closely comparable to Labyes' therapeutic line-up and small-animal focus.
  • Vetoquinol: Independent global animal health group focused on companion animals and livestock with strong LATAM presence. Directly comparable to Labyes in product mix (parasiticides, anti-infectives, dermatology) and family-controlled governance.
  • Ceva Santé Animale: Privately held global animal health company with leadership positions in companion-animal pharmaceuticals, vaccines, and devices. Comparable in scale, specialty pharma focus, and privately held structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Labyes social profiles

Digital presence

Labyes compliance and trust

Trust signal

Compliance3 records

Labyes financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Labyes leadership team

Management profile

Number of profiles

Labyes subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Labyes funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Labyes M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labyes

What does Labyes do?

Labyes develops, manufactures, and distributes proprietary veterinary pharmaceutical products for small animals (dogs and cats). Founded in 1985 in Argentina, the company supplies its products through authorized distributors across approximately 20 countries, with regulatory oversight requiring a registered veterinarian as Technical Director.

Is Labyes a public or private company?

Labyes is a private company. It is currently operating.

When was Labyes founded?

Labyes was founded in 1985. It employs 51 to 100 people.

Where is Labyes based?

Labyes is headquartered in Moron, Argentina, in the Latin America region.

How does Labyes make money?

One revenue line is on record: veterinary pharmaceutical product sales.

Who are Labyes's main competitors?

Regional players on record are Vetnil and Ourofino Pet. Broad incumbents are MSD Animal Health (Merck Animal Health), Elanco Animal Health, Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Virbac, Dechra Pharmaceuticals, Vetoquinol and Ceva Santé Animale.

Does Labyes have an API?

No public API is recorded for Labyes.

What industry is Labyes in?

Labyes's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAM, Generic & Private-Label Veterinary Pharmaceuticals, with a secondary code of HLAMAEAF, Pain Management, Anesthesia & Critical Care Drugs. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales